Nanjing Pharmaceutical Group Company Limited (SHA:600713)
4.990
+0.030 (0.60%)
Oct 28, 2026, 3:00 PM CST
| Market Cap | 6.53B -2.4% |
| Revenue (ttm) | 54.82B +0.7% |
| Net Income | 628.03M +14.1% |
| EPS | 0.43 +6.6% |
| Shares Out | 1.31B |
| PE Ratio | 11.72 |
| Forward PE | n/a |
| Dividend | 0.18 (3.61%) |
| Ex-Dividend Date | Sep 17, 2026 |
| Volume | 7,650,400 |
| Open | 4.960 |
| Previous Close | 4.960 |
| Day's Range | 4.920 - 4.990 |
| 52-Week Range | 4.780 - 6.650 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |